DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,649,969 | -14.2% | 2,016,507 | -5.1% | 0.01% | -16.7% |
| Q2 2023 | $29,906,398 | -36.7% | 2,124,034 | -30.5% | 0.01% | -40.0% |
| Q1 2023 | $47,244,756 | -27.1% | 3,057,913 | -22.6% | 0.01% | -28.6% |
| Q4 2022 | $64,779,393 | -7.0% | 3,952,373 | +4.9% | 0.01% | -12.5% |
| Q3 2022 | $69,687,000 | +44.6% | 3,766,853 | +2.8% | 0.02% | +45.5% |
| Q2 2022 | $48,179,000 | +547.8% | 3,663,819 | +356.7% | 0.01% | +450.0% |
| Q1 2022 | $7,437,000 | -79.1% | 802,177 | -77.9% | 0.00% | -71.4% |
| Q4 2021 | $35,519,000 | +141.4% | 3,635,510 | +739.6% | 0.01% | +133.3% |
| Q3 2021 | $14,713,000 | -3.2% | 432,983 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $15,201,000 | -45.4% | 415,214 | -33.1% | 0.00% | -57.1% |
| Q1 2021 | $27,826,000 | -16.6% | 620,541 | +6.1% | 0.01% | -22.2% |
| Q4 2020 | $33,363,000 | +90.3% | 584,601 | +71.1% | 0.01% | +80.0% |
| Q3 2020 | $17,528,000 | -48.5% | 341,674 | -40.1% | 0.01% | -50.0% |
| Q2 2020 | $34,063,000 | +58.3% | 570,375 | +9.1% | 0.01% | +42.9% |
| Q1 2020 | $21,515,000 | +10.8% | 522,597 | +67.6% | 0.01% | +40.0% |
| Q4 2019 | $19,413,000 | +203.9% | 311,895 | +65.7% | 0.01% | +400.0% |
| Q3 2019 | $6,387,000 | +736.0% | 188,179 | +455.5% | 0.00% | – |
| Q2 2019 | $764,000 | -43.4% | 33,873 | -41.7% | 0.00% | – |
| Q1 2019 | $1,349,000 | +56.3% | 58,117 | +41.3% | 0.00% | – |
| Q4 2018 | $863,000 | +87.2% | 41,118 | +245.6% | 0.00% | – |
| Q3 2018 | $461,000 | +120.6% | 11,898 | +124.5% | 0.00% | – |
| Q2 2018 | $209,000 | -19.6% | 5,299 | -59.2% | 0.00% | – |
| Q1 2018 | $260,000 | -81.7% | 12,977 | -82.7% | 0.00% | – |
| Q3 2017 | $1,424,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |